Actively Recruiting

Phase Not Applicable
Age: 50Years - 80Years
All Genders
Healthy Volunteers
ID07451496

PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS)

Led by National University of Singapore · Updated on 2026-03-05

20

Participants Needed

1

Research Sites

18 weeks

Total Duration

On this page

Sponsors

N

National University of Singapore

Lead Sponsor

X

Xprize Foundation

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to evaluate a personalized precision geromedicine approach designed to improve key aging hallmarks and promote healthy aging in adults aged 50 to 80 years. The study focuses on middle-aged to older individuals who have lower than average cardiorespiratory fitness and cognitive performance, targeting early declines in muscle, immune, and cognitive functions to enhance overall healthspan and delay functional deterioration. Participants will undergo an 8-week multimodal intervention that includes lifestyle changes, dietary supplements, and supervised exercise with an exergaming component. Two groups receive either a fundamental lifestyle intervention with nutritional supplements or an augmented intervention with additional personalized supplements based on baseline muscle mass, fitness, and cognitive assessments, with possible adjustments mid-study. Throughout the study, participants will attend regular assessments to track changes in fitness, muscle strength and mass, cognitive function, immune markers, and other biological and clinical indicators. These evaluations occur at baseline, week 4, and week 8, involving physical tests, imaging, cognitive batteries, and blood analyses. The study also monitors adherence, quality of life, and well-being during the intervention period.

CONDITIONS

Brief Title

PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS)

Who Can Participate

Age: 50Years - 80Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 50-80 years, male or female
  • Generally healthy and stable health condition
  • Not regularly engaged in resistance or aerobic training in past 12 months
  • Cardiorespiratory fitness (VO2peak) below 75th percentile for age and sex
  • Cognitive performance below 75th percentile on NIH Toolbox Cognitive Battery
  • Willing and able to follow exercise and supplementation protocols
  • Able to read and understand English
  • Provides written informed consent
  • Assessed to have mental capacity by Principal Investigator
  • Able to attend all research visits at study site
Not Eligible

You will not qualify if you...

  • Significant medication changes in past 3 months
  • History of major cardiovascular disease (e.g., coronary artery disease, heart failure, stroke)
  • More than two unstable chronic conditions (e.g., hypertension, diabetes, osteoarthritis, COPD)
  • Known allergies to soy, shellfish/seaweed, mushrooms, or supplement ingredients
  • Participation in another interventional clinical trial
  • Current use of study supplements unless willing to stop
  • Medical, psychiatric, or cognitive conditions that risk safety or compliance
  • Pregnant or planning pregnancy during study period
  • Any condition deemed by Principal Investigator to pose safety or compliance risks

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 8 weeks

Participants undergo an 8-week personalized intervention combining lifestyle modifications, supervised exercise with cognitive tasks and exergaming, motivational interviewing, and tailored nutritional supplementation based on individual assessments.

Weekly visits during the 8-week intervention and 2 motivational interviewing sessions

Trial Site Locations

Total: 1 location

1

MD11 Clinical Research Centre, #03-01, 10 Medical Drive, Singapore 117597

Singapore, Singapore, Singapore, 117597

Actively Recruiting

Loading map...

Research Team

A

Ajla Hodzic Kuerec, MD, PhD

M

Mazzarine Dotou, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here